These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2500463)

  • 1. Differentiation of stereotypies from neuroleptic-related dyskinesias in autistic children.
    Meiselas KD; Spencer EK; Oberfield R; Peselow ED; Angrist B; Campbell M
    J Clin Psychopharmacol; 1989 Jun; 9(3):207-9. PubMed ID: 2500463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic-related dyskinesias and stereotypies in autistic children: videotaped ratings.
    Shay J; Sanchez LE; Cueva JE; Armenteros JL; Overall JE; Campbell M
    Psychopharmacol Bull; 1993; 29(3):359-63. PubMed ID: 7907183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotypies and tardive dyskinesia: abnormal movements in autistic children.
    Campbell M; Locascio JJ; Choroco MC; Spencer EK; Malone RP; Kafantaris V; Overall JE
    Psychopharmacol Bull; 1990; 26(2):260-6. PubMed ID: 2236468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tourette-like symptoms associated with neuroleptic therapy in an autistic child.
    Perry R; Nobler MS; Campbell M
    J Am Acad Child Adolesc Psychiatry; 1989 Jan; 28(1):93-6. PubMed ID: 2914842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic-related dyskinesias in autistic children: a prospective study.
    Perry R; Campbell M; Green WH; Small AM; Die Trill ML; Meiselas K; Golden RR; Deutsch SI
    Psychopharmacol Bull; 1985; 21(1):140-3. PubMed ID: 3885290
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study.
    Campbell M; Armenteros JL; Malone RP; Adams PB; Eisenberg ZW; Overall JE
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):835-43. PubMed ID: 9183140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors related to haloperidol response and dyskinesias in autistic children.
    Locascio JJ; Malone RP; Small AM; Kafantaris V; Ernst M; Lynch NS; Overall JE; Campbell M
    Psychopharmacol Bull; 1991; 27(2):119-26. PubMed ID: 1924657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated episodes of neuroleptic-related dyskinesias in autistic children.
    Malone RP; Ernst M; Godfrey KA; Locascio JJ; Campbell M
    Psychopharmacol Bull; 1991; 27(2):113-7. PubMed ID: 1681562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haloperidol-related dyskinesias and pre- and perinatal complications in autistic children.
    Armenteros JL; Adams PB; Campbell M; Eisenberg ZW
    Psychopharmacol Bull; 1995; 31(2):363-9. PubMed ID: 7491393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of haloperidol in young autistic children: a within-subjects design using objective rating scales.
    Cohen IL; Campbell M; Posner D
    Psychopharmacol Bull; 1980 Jul; 16(3):63-5. PubMed ID: 7403407
    [No Abstract]   [Full Text] [Related]  

  • 11. Spontaneous orofacial dyskinesias in a captive cynomolgus monkey: implications for tardive dyskinesia.
    Rupniak NM; Tye SJ; Steventon MJ; Boyce S; Iversen SD
    Mov Disord; 1990; 5(4):314-8. PubMed ID: 2259355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.
    Perry R; Campbell M; Adams P; Lynch N; Spencer EK; Curren EL; Overall JE
    J Am Acad Child Adolesc Psychiatry; 1989 Jan; 28(1):87-92. PubMed ID: 2914841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor stereotypies in children with autism and other developmental disorders.
    Goldman S; Wang C; Salgado MW; Greene PE; Kim M; Rapin I
    Dev Med Child Neurol; 2009 Jan; 51(1):30-8. PubMed ID: 19087102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the phenomenon of autistic regression using home videotapes.
    Werner E; Dawson G
    Arch Gen Psychiatry; 2005 Aug; 62(8):889-95. PubMed ID: 16061766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Psychopharmacology of autism].
    Chabrol H; Bonnet D; Roge B
    Encephale; 1996; 22(3):197-203. PubMed ID: 8767048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of live and videotape ratings: clomipramine and haloperidol in autism.
    Sanchez LE; Adams PB; Uysal S; Hallin A; Campbell M; Small AM
    Psychopharmacol Bull; 1995; 31(2):371-8. PubMed ID: 7491394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone: new indication. Behavioural disorders in children with autism or mental disabilities: no progress.
    Prescrire Int; 2006 Apr; 15(82):43-5. PubMed ID: 16602211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characterization and outcome of stereotypical movements in nonautistic children.
    Tan A; Salgado M; Fahn S
    Mov Disord; 1997 Jan; 12(1):47-52. PubMed ID: 8990053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol withdrawal and weight changes in autistic children.
    Silva RR; Malone RP; Anderson LT; Shay J; Campbell M
    Psychopharmacol Bull; 1993; 29(2):287-91. PubMed ID: 8290679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.